Chronic wounds can be a serious health issue for many individuals, particularly those with diabetes or poor blood circulation. In some cases, these wounds can even lead to amputation. However, researchers at Chalmers University of Technology in Sweden and the University of Freiburg in Germany have developed a promising solution using electric stimulation to speed up the healing process.
Electric Stimulation and Bioengineering
The team worked from an old hypothesis that electric stimulation of damaged skin can be used to heal wounds. Skin cells are electrotactic, which means they move in the direction of an electric field. The researchers investigated how this principle can be used to electrically guide the cells and speed up the healing process.
Using an engineered chip, the researchers were able to compare wound healing in artificial skin, stimulating one wound with electricity and letting one heal without electricity. The results showed that wounds healed three times faster with electric stimulation than without.
A Win for Diabetics & Individualized Treatment
The team also looked at wound healing in connection with diabetes, a growing health problem worldwide. They found that their method could significantly increase the speed of healing for diabetes-affected cells.
The researchers recently received a large grant to continue their research and eventually develop wound healing products for consumers. However, more basic research is required to develop effective products that generate enough electric field strength and stimulate in the right way for each individual.
Maria Asplund, Associate Professor of Bioelectronics at Chalmers University of Technology and head of research on the project, states that the team aims to develop a concept to be able to “scan” wounds and adapt the stimulation based on the individual wound. She believes that this is the key to effectively helping individuals with slow-healing wounds in the future.
Funding and Impact
The team’s work was published in the journal Lab on a Chip, and their research project is funded by the European Research Council (ERC). The potential impact of their discovery is enormous, as chronic wounds are a huge societal problem that affect many people. This new method could be a game changer, offering hope and healing to those who suffer from slow-healing wounds.
Study DOI: https://doi.org/10.1039/D2LC01045C

Light-programmable ion channels and signaling opsins now enable mechanistic dissection and targeted control of cardiac rhythms from single cells to whole hearts.

Oxidative stress in the lacrimal gland and ocular surface represents both a protector and a pathogen, demanding therapies that navigate its paradoxical biology.
Igor Nasonkin’s systems-driven approach at Phythera Therapeutics reframes oncology drug development from single-target inhibition to AI-enabled polypharmacologic network modulation using nature-derived molecular architectures.
Devin Swanson’s leadership at Johnson & Johnson Innovative Medicines redefines external innovation as a tightly governed, AI-enabled translational system integrating multi-modal drug discovery, biomarker strategy, and capital-efficient execution.
A systems-level examination of how Mehran F. Moghaddam operationalizes DMPK, externalized R&D, and lipid-mediated therapeutics into a predictive, high-velocity biotech development architecture.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings